Bextra Contraindicated In CABG Surgery Patients

Labeling change to add "black box" for serious skin reactions incorporates post-surgery safety data, including results from two coronary artery bypass graft trials that show increased cardiovascular risk with Pfizer's COX-2 inhibitor.

More from Archive

More from Pink Sheet